BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 25593345)

  • 21. Solitary pulmonary nodules: morphological and metabolic characterisation by FDG-PET-MDCT.
    Orlacchio A; Schillaci O; Antonelli L; D'Urso S; Sergiacomi G; Nicolì P; Simonetti G
    Radiol Med; 2007 Mar; 112(2):157-73. PubMed ID: 17361379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Test performance of sputum microRNAs for lung cancer: a meta-analysis.
    Liao QB; Guo JQ; Zheng XY; Zhou ZF; Li H; Lai XY; Ye JF
    Genet Test Mol Biomarkers; 2014 Aug; 18(8):562-7. PubMed ID: 24892736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prediction model based on DNA methylation biomarkers and radiological characteristics for identifying malignant from benign pulmonary nodules.
    Xing W; Sun H; Yan C; Zhao C; Wang D; Li M; Ma J
    BMC Cancer; 2021 Mar; 21(1):263. PubMed ID: 33691657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Differential diagnosis of benign and malignant solitary pulmonary nodule with computer-aided detection].
    Wang MP; Tan YQ; Zhang GZ; Zhang JG; Wu H; Yang JY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Feb; 28(1):64-7. PubMed ID: 16548192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic value of PET/CT in differentiating benign from malignant solitary pulmonary nodules.
    Dalli A; Selimoglu Sen H; Coskunsel M; Komek H; Abakay O; Sergi C; Cetin Tanrikulu A
    J BUON; 2013; 18(4):935-41. PubMed ID: 24344020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 99mTc-tetrofosmin SPECT in solitary pulmonary nodule evaluation.
    Spanu A; Schillaci O; Pirina P; Arru A; Madeddu G; Chessa F; Marongiu P; Solinas ME; Madeddu G
    Oncol Rep; 2006 Oct; 16(4):763-9. PubMed ID: 16969491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical application of pharmacokinetic analysis as a biomarker of solitary pulmonary nodules: dynamic contrast-enhanced MR imaging.
    Mamata H; Tokuda J; Gill RR; Padera RF; Lenkinski RE; Sugarbaker DJ; Butler JP; Hatabu H
    Magn Reson Med; 2012 Nov; 68(5):1614-22. PubMed ID: 22231729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules.
    Swensen SJ; Silverstein MD; Ilstrup DM; Schleck CD; Edell ES
    Arch Intern Med; 1997 Apr; 157(8):849-55. PubMed ID: 9129544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A clinical model to estimate the pretest probability of lung cancer in patients with solitary pulmonary nodules.
    Gould MK; Ananth L; Barnett PG;
    Chest; 2007 Feb; 131(2):383-8. PubMed ID: 17296637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination diagnosis of multi-slice spiral computed tomography and secretary phospholipase A2-IIa for solitary pulmonary nodules.
    Hou H; Xu Z; Zhang H; Xu Y
    J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28493533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT.
    Christensen JA; Nathan MA; Mullan BP; Hartman TE; Swensen SJ; Lowe VJ
    AJR Am J Roentgenol; 2006 Nov; 187(5):1361-7. PubMed ID: 17056930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of small nucleolar RNAs in sputum for lung cancer diagnosis.
    Su J; Liao J; Gao L; Shen J; Guarnera MA; Zhan M; Fang H; Stass SA; Jiang F
    Oncotarget; 2016 Feb; 7(5):5131-42. PubMed ID: 26246471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrating DNA methylation and microRNA biomarkers in sputum for lung cancer detection.
    Su Y; Fang H; Jiang F
    Clin Epigenetics; 2016; 8():109. PubMed ID: 27777637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Videothoracoscopic management of the solitary pulmonary nodule: a single-institution study on 429 cases.
    Cardillo G; Regal M; Sera F; Di Martino M; Carbone L; Facciolo F; Martelli M
    Ann Thorac Surg; 2003 May; 75(5):1607-11; discussion 1611-2. PubMed ID: 12735587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Repeat needle biopsies combined with clinical observation are safe and accurate in the management of a solitary pulmonary nodule.
    Welker JA; Alattar M; Gautam S
    Cancer; 2005 Feb; 103(3):599-607. PubMed ID: 15630699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Proteomic Features To Distinguish Benign Pulmonary Nodules from Lung Adenocarcinoma.
    Codreanu SG; Hoeksema MD; Slebos RJC; Zimmerman LJ; Rahman SMJ; Li M; Chen SC; Chen H; Eisenberg R; Liebler DC; Massion PP
    J Proteome Res; 2017 Sep; 16(9):3266-3276. PubMed ID: 28731711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of circulating rare cells benefitted the diagnosis of malignant solitary pulmonary nodules.
    Xie J; Ruan Z; Zheng J; Gong Y; Wang Y; Hu B; Cheng J; Huang Q
    J Cancer Res Clin Oncol; 2022 Oct; 148(10):2681-2692. PubMed ID: 34791530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of benign solitary pulmonary nodules confirmed by diagnostic video-assisted thoracoscopic surgery.
    Choi SM; Heo EY; Lee J; Park YS; Lee CH; Park CM; Kang CH; Yim JJ; Kim YT; Yoo CG; Han SK; Kim YW
    Clin Respir J; 2016 Mar; 10(2):181-8. PubMed ID: 25103572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Establishment of A Clinical Prediction Model of Solid Solitary Pulmonary Nodules].
    Yu W; Ye B; Xu L; Wang Z; Le H; Wang S; Cao H; Chai Z; Chen Z; Luo Q; Zhang Y
    Zhongguo Fei Ai Za Zhi; 2016 Oct; 19(10):705-710. PubMed ID: 27760603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the discriminative methods for diagnosis of benign and malignant solitary pulmonary nodules based on serum markers.
    Wang W; Liu M; Wang J; Tian R; Dong J; Liu Q; Zhao X; Wang Y
    Oncol Res Treat; 2014; 37(12):740-6. PubMed ID: 25531720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.